GGrantIndex
Sort

64,565 grants matching drug discovery

Neural Oscillatory Biomarkers for Genetics and Animal Models of Schizophrenia

$525,716
L. Elliot Hong · University Of Maryland Baltimore · R01 · FY2013 · MH

Validation and Application of a Model for Human-like TB Latency in Rabbits

$525,694
David Alland · Rbhs-New Jersey Medical School · U19 · FY2020 · AI

Development of Dual GABAA and alpah7 Nicotinic Receptor Modulators for AD

$525,669
Kelvin W Gee · University Of California-Irvine · U01 · FY2009 · AG

SELF-SPLICING INTEINS: FUNCTION, EVOLUTION, APPLICATION

$525,626
Marlene Belfort · State University Of New York At Albany · R01 · FY2012 · GM

Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population

$525,583
Joanne E Curran · University Of Texas Rio Grande Valley · R01 · FY2023 · DK

BCR-ABL Kinase Assays for STI571 Sensitivity of Response

$525,569
Stephen J. Kron · University Of Chicago · R33 · FY2006 · CA

Biofabricated 3-D skin model for antiviral drug discovery against human HSV infection

$525,536
Jia Zhu · University Of Washington · U18 · FY2020 · TR

Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease

$525,512
Antony Rodriguez · Baylor College Of Medicine · R01 · FY2023 · HL

Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease

$525,512
Antony Rodriguez · Baylor College Of Medicine · R01 · FY2025 · HL

MATERIALS WITH PHYSIOLOGICAL PROPERTIES

$525,505
Harvard University · R37 · FY2000 · GM

Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection

$525,483
Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI

A Combined Approach to Targeted Antiherpesvirus Drugs

$525,469
Donald M Coen · Harvard Medical School · R01 · FY2007 · AI

A Combined Approach to Targeted Antiherpesvirus Drugs

$525,404
Donald M Coen · Harvard Medical School · R01 · FY2006 · AI

GenHAT

$525,391
John H Eckfeldt · University Of Minnesota · R01 · FY2007 · HL

Develop High-Precision and Multiplex Base Editing Approaches for Therapeutic Applications

$525,357
Xue Gao · Rice University · R01 · FY2021 · HL

Develop High-Precision and Multiplex Base Editing Approaches for Therapeutic Applications

$525,357
Xue Gao · Rice University · R01 · FY2022 · HL

Develop High-Precision and Multiplex Base Editing Approaches for Therapeutic Applications

$525,357
Xue Gao · Rice University · R01 · FY2023 · HL

Estrogen receptor mediated reprogramming of prostate in BPH

$525,283
Paul S Cooke · University Of Florida · R01 · FY2018 · DK

Training program in cancer pharmacology

$525,255
Ian Alexander Blair · University Of Pennsylvania · R25 · FY2010 · CA

Exploring the metabolism of non-replicating and drug-resistant TB

$525,226
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Experimental Animal Models of TB: Chemotherapeutics and Imaging

$525,226
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Development Of New Chemotherapeutics For Tuberculosis

$525,226
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Chemoproteomic methods for serine hydrolase inhibitor development

$525,195
Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2016 · DA

Genetic etiology of Amyotrophic Lateral Sclerosis

$525,138
Bryan Traynor · National Institute On Aging · ZIA · FY2025 · AG

Predicting Brain Changes in HIV/AIDS

$525,081
Paul M Thompson · University Of Southern California · R01 · FY2014 · NS